annb0t
Top 20
MELBOURNE, Australia and INDIANAPOLIS, April 4, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces that its prostate cancer imaging agent, Illuccix® (kit for preparation of gallium Ga 68 gozetotide), also known as 68Ga-PSMA-11 injection, is now commercially available in the United States. (PRNewsfoto/Telix Pharmaceuticals Limited)
Illuccix is available to order from 117 Cardinal Health and PharmaLogic pharmacies, delivering coverage to ~85% of PET1 im...
>>> Read more: Commercial Launch: Illuccix® Now Available to Order in the United States
Illuccix is available to order from 117 Cardinal Health and PharmaLogic pharmacies, delivering coverage to ~85% of PET1 im...
>>> Read more: Commercial Launch: Illuccix® Now Available to Order in the United States
